Head-to-head for women
Alloy vs Ro
Alloy and Ro both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Alloy
Ranked #41 for women · Grade B−
Luna Fit
Best for: Women in perimenopause or menopause who want the clinician managing their weight to be the same one who understands their hormones — and who can absorb a membership fee on top of the drug price.
Visit AlloyRo
Higher scoreRanked #28 for women · Grade B
Luna Fit
Best for: Women who want brand-name medication and insurance support, and are comfortable with a big, polished platform.
Visit RoThe verdict for women
Ro edges out Alloy on the Luna Fit Score, 86 to 82 (B vs B−). Women who want brand-name medication and insurance support, and are comfortable with a big, polished platform. The reasoning behind that number is in our full Ro review.
Alloy is still a genuine option — the only program in this ranking built for midlife first: your prescriber is a Menopause Society–certified physician, and weight care sits alongside a full hormone-therapy line rather than being sold in isolation. Weigh the six women's-health factors below against your own priorities; what we found reviewing Alloy goes through each of them, and if neither of these two is the one, the Alloy alternatives, scored on the same six factors widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Alloy | Ro |
|---|---|---|
| Luna Fit Score | 82/100 · B− | 86/100 · B |
| Overall rank | #41 | #28 |
| Semaglutide | From $169/mo all-in ($70 medication + $99 membership) | Not disclosed |
| Tirzepatide | From $199/mo all-in ($100 medication + $99 membership) | Not disclosed |
| Coverage | Not disclosed; compounded excluded in 6 states and DC | Multi-state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Luna Fit
Alloy
Ranked #41 · Grade B−
What we like
- Prescribers hold the Menopause Society Certified Practitioner credential — the only ranking entry where that is true of named clinicians
- The widest formulary here: compounded semaglutide, tirzepatide and liraglutide, plus brand Wegovy, Zepbound and the Wegovy and Foundayo pills
- Oral routes are FDA-approved brand pills, not a compounded workaround, for women who will not inject
The caveats
- The $99/mo membership is charged on top of every medication price, so the headline figure is not what you pay
- Every price is quoted 'starting at' with no published dose table — the rate can move as you titrate
- Compounded medication is unavailable in six states and DC, and the overall coverage footprint is not published anywhere on the site
Luna Fit
Ro
Ranked #28 · Grade B
What we like
- Brand-name (Wegovy/Zepbound) access and insurance navigation
- Oral options and a well-funded, polished experience
- Strong clinical infrastructure
The caveats
- Does not publicly disclose compounded pricing up front
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Alloy nor Ro is only worth comparing with the other. Alloy is also written up against CoreAge Rx, 11 points apart on the Luna Fit Score — see Alloy vs CoreAge Rx for women. Ro is also written up against Eden, 2 points apart — see the Ro–Eden head-to-head.
Or browse the full comparison hub.